Modulating metals as a therapeutic strategy for Alzheimer’s disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulating metals as a therapeutic strategy for Alzheimer’s disease
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 4, Issue 8, Pages 955-969
Publisher
Future Science, LTD
Online
2012-06-01
DOI
10.4155/fmc.12.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Bis (thiosemicarbazonato) Cu-64 Complexes for Positron Emission Tomography Imaging of Alzheimer's Disease
- (2017) Michelle T. Fodero-Tavoletti et al. JOURNAL OF ALZHEIMERS DISEASE
- Stem cell technology for neurodegenerative diseases
- (2011) J. Simon Lunn et al. ANNALS OF NEUROLOGY
- The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
- (2011) Peter J. Crouch et al. JOURNAL OF NEUROCHEMISTRY
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
- (2010) James A. Duce et al. CELL
- Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease?
- (2010) P. A. Adlard et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's failure raises questions about disease-modifying strategies
- (2010) Andy Extance NATURE REVIEWS DRUG DISCOVERY
- Alterations of Zinc Transporter Proteins ZnT-1, ZnT-4 and ZnT-6 in Preclinical Alzheimer's Disease Brain
- (2009) Ganna Lyubartseva et al. BRAIN PATHOLOGY
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tau oligomers and aggregation in Alzheimer’s disease
- (2009) Marco A. Meraz-Ríos et al. JOURNAL OF NEUROCHEMISTRY
- -Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of -Carboxyl Terminal Fragment
- (2009) M. Takami et al. JOURNAL OF NEUROSCIENCE
- Increasing Cu bioavailability inhibits A oligomers and tau phosphorylation
- (2009) P. J. Crouch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Closer Look at α-Secretase
- (2008) Rolf Postina Current Alzheimer Research
- Intramembrane Proteolysis by γ-Secretase
- (2008) Harald Steiner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of GSK-3 activation and 7 nAChRs in A142-induced tau phosphorylation in PC12 cells
- (2008) Min Hu et al. JOURNAL OF NEUROCHEMISTRY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More